Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wilex AG

www.wilex.com

Latest From Lederle Laboratories

Fertility Market Poised For Growth Spurt After Fallow Decade

Late-stage pipeline is dominated by follicle stimulating hormones, split between “biobetters” and biosimilars. Next-generation oxytocin antagonists are leading candidates for the next novel entities in infertility.

BioPharmaceutical

Watson Becomes Actavis: Name Change To Reflect Greater International Focus

Watson’s merger with Actavis will create the world’s third-largest generic drug company, to be known as Actavis, with significant ex-U.S. market share, especially in the U.K., Nordic countries and Russia.

BioPharmaceutical North America

Watson/Actavis: Name Is Just One Of Many Changes Resulting From Merger Completion

With the Actavis deal finalized, Watson achieves its long-sought goal of becoming a major international player in generics, and announces a new global management team to undertake the critical component: execution.

BioPharmaceutical North America

ANDA Graveyard: FDA Begins Weeding Out Inactive Generic Applications

The agency issued a list of 364 ANDAs that will be deemed withdrawn unless the sponsor tells FDA it wishes to pursue them; it is a first step in clearing the backlog before generic drug user fees are enacted.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Wilex Biotechnology GMBH
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Wilex AG
  • Senior Management
  • Jan Schmidt-Brand, PhD, CFO
    Andreas Pahl, Head, R&D
  • Contact Info
  • Wilex AG
    Phone: (49) 89 41 31 38 0
    Grillparzerstr. 10
    Munich, 81675
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register